记忆性T细胞在慢性自身免疫性皮肤病中的研究进展

doi:10.35541/cjd.20230193

Abstract

Abstract: 【Abstract】 Chronic autoimmune skin diseases are a large group of skin diseases in which the inflammatory response is caused by the body′s immune response to self-antigenic substances. Autoreactive memory T cells can recognize specific autoantigens, and are able to chronically stimulate immune responses, thereby maintaining chronic inflammation of the skin and causing relapse. Targeted therapies hold promise as an effective means of controlling the relapse of chronic autoimmune skin diseases. This review summarizes research advances in the role of memory T cells in chronic autoimmune skin diseases.

Key words: T-lymphocytes, Vitiligo, Psoriasis, Lupus erythematosus, cutaneous, Memory T cells, Immunotherapy

Hu Ying, Jiao Qingqing. Memory T cells in chronic autoimmune skin diseases[J]. Chinese Journal of Dermatology,2023,e20230193. doi:10.35541/cjd.20230193

References ［26］

［1］	Boniface K, Jacquemin C, Darrigade A S, et al. Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3 ［J］. J Invest Dermatol, 2018,138（2）:355⁃364. doi: 10.1016/j.jid.2017.08.038.
［2］	Chen L, Shen Z. Tissue⁃resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders［J］. Cell Mol Immunol, 2020,17（1）:64⁃75. doi: 10. 1038/s41423⁃019⁃0291⁃4.
［3］	Cheuk S, Schlums H, Gallais Sérézal I, et al. CD49a expression defines tissue⁃resident CD8（+） T cells poised for cytotoxic function in human skin［J］. Immunity, 2017,46（2）:287⁃300. doi: 10.1016/j.immuni.2017.01.009.
［4］	Kurihara K, Fujiyama T, Phadungsaksawasdi P, et al. Signifi⁃cance of IL⁃17A⁃producing CD8（+）CD103（+） skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course［J］. J Dermatol Sci, 2019,95（1）:21⁃27. doi: 10.1016/j.jdermsci.2019.06.002.
［5］	Lee Y J, Park J A, Kwon H, et al. Role of stem cell⁃like memory T cells in systemic lupus erythematosus［J］. Arthritis Rheumatol, 2018,70（9）:1459⁃1469. doi: 10.1002/art.40524.
［6］	Fazeli P, Talepoor AG, Faghih Z, et al. The frequency of CD4+ and CD8+ circulating T stem cell memory in type 1 diabetes［J］. Immun Inflamm Dis, 2022,10（10）:e715. doi: 10.1002/iid3.715.
［7］	Ryan GE, Harris JE, Richmond JM. Resident memory T cells in autoimmune skin diseases［J］. Front Immunol, 2021,12:652191. doi: 10.3389/fimmu.2021.652191.
［8］	Hosokawa K, Muranski P, Feng X, et al. Memory stem T cells in autoimmune disease: high frequency of circulating CD8+ memory stem cells in acquired aplastic anemia ［J］. J Immunol, 2016,196（4）:1568⁃1578.doi:10.4049/jimmunol.1501739.
［9］	Hadi A, Wang JF, Uppal P, et al. Comorbid diseases of vitiligo: a 10⁃year cross⁃sectional retrospective study of an urban US population［J］. J Am Acad Dermatol, 2020,82（3）:628⁃633. doi: 10.1016/j.jaad.2019.07.036.
［10］	Lin F, Sun X, Lei J, et al. Altered circulating memory T cells in vitiligo cases followed NB⁃UVB therapy［J］. Photodermatol Photoimmunol Photomed, 2022,38（1）:76⁃82. doi: 10.1111/phpp. 12719.
［11］	Martins C, Darrigade AS, Jacquemin C, et al. Phenotype and function of circulating memory T cells in human vitiligo［J］. Br J Dermatol, 2020,183（5）:899⁃908. doi: 10.1111/bjd.18902.
［12］	Fujiyama T, Umayahara T, Kurihara K, et al. Skin infiltration of pathogenic migratory and resident T cells is decreased by secukinumab treatment in psoriasis［J］. J Invest Dermatol, 2020,140（10）:2073⁃2076.e6. doi: 10.1016/j.jid.2020.02.024.
［13］	Kasprowicz⁃Furmańczyk M, Czerwińska J, Placek W, et al. Assessment of the tissue resident memory cells in lesional skin of patients with psoriasis and in healthy skin of healthy volunteers［J］. Int J Environ Res Public Health, 2021,18（21）doi: 10.3390/ijerph182111251.
［14］	Phadungsaksawasdi P, Fujiyama T, Kurihara K, et al. PD⁃1 expression defines epidermal CD8（+）CD103（+） T cells preferentially producing IL⁃17A and using skewed TCR repertoire in psoriasis［J］. J Invest Dermatol, 2021,141（10）:2426⁃2435.e5. doi: 10.1016/j.jid.2021.03.011.
［15］	Suzuki K, Suzuki K, Yabe Y, et al. NF⁃κB1 contributes to imiquimod⁃induced psoriasis⁃like skin inflammation by inducing Vγ4（+）Vδ4（+）γδT17 cells［J］. J Invest Dermatol, 2022,142（6）:1639⁃1649.e5. doi: 10.1016/j.jid.2021.11.004.
［16］	Zhao Z, Zhu H, Li Q, et al. Skin CD4（+） Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases［J］. J Autoimmun, 2022,128:102811. doi: 10.1016/j.jaut.2022.102811.
［17］	Gu HJ, Song S, Roh JY, et al. Expression pattern of tissue⁃resident memory T cells in cutaneous lupus erythematosus［J］. Lupus, 2021,30（9）:1427⁃1437. doi: 10.1177/09612033211017218.
［18］	袁祥, 周滢波, 王其凯,等. 系统性红斑狼疮组织原位记忆T细胞表达与皮损相关性研究［J］. 中华风湿病学杂志, 2017,21（10）:680⁃684,722. doi: 10.3760/cma.j.issn.1007⁃7480.2017.10. 007.
［19］	Chen X, Guo W, Chang Y, et al. Oxidative stress⁃induced IL⁃15 trans⁃presentation in keratinocytes contributes to CD8（+） T cells activation via JAK⁃STAT pathway in vitiligo［J］. Free Radic Biol Med, 2019,139:80⁃91. doi: 10.1016/j.freeradbiomed. 2019.05.011.
［20］	Richmond JM, Strassner JP, Zapata L, et al. Antibody blockade of IL⁃15 signaling has the potential to durably reverse vitiligo［J］. Sci Transl Med, 2018,10（450）:eaan7710. doi: 10.1126/scitranslmed.aam7710.
［21］	Martins C, Migayron L, Drullion C, et al. Vitiligo skin T cells are prone to produce type 1 and type 2 cytokines to induce melanocyte dysfunction and epidermal inflammatory response through Jak signaling［J］. J Invest Dermatol, 2022,142（4）:1194⁃1205.e7. doi: 10.1016/j.jid.2021.09.015.
［22］	Azzolino V, Zapata L Jr, Garg M, et al. Jak inhibitors reverse vitiligo in mice but do not deplete skin resident memory T cells［J］. J Invest Dermatol, 2021,141（1）:182⁃184.e1. doi: 10.1016/j.jid.2020.04.027.
［23］	Song H, Hu Z, Zhang S, et al. Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real⁃world clinical practice［J］. Dermatol Ther, 2022,35（11）:e15821. doi: 10.1111/dth.15821.
［24］	Mehta H, Mashiko S, Angsana J, et al. Differential changes in inflammatory mononuclear phagocyte and T⁃cell profiles within psoriatic skin during treatment with guselkumab vs. secukinumab［J］. J Invest Dermatol, 2021,141（7）:1707⁃1718.e9. doi: 10. 1016/j.jid.2021.01.005.
［25］	Chen Y, Yan Y, Liu H, et al. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8（+） T⁃cell memory in wild⁃type and humanized mice［J］. Theranostics, 2020,10（23）:10466⁃10482. doi: 10.7150/thno.45211.
［26］	Pan Y, Tian T, Park C O, et al. Survival of tissue⁃resident memory T cells requires exogenous lipid uptake and metabolism ［J］. Nature, 2017,543（7644）:252⁃256. doi: 10.1038/nature21379.

[1]	Xue Tianping, Lu Zhenzhong, Wang Hongsheng. Relationship between the pathogenesis of psoriasis and microbial flora [J]. Chinese Journal of Dermatology, 2026, 59(1): 89-92.
[2]	Wang Xia, Xiang Jiyuan, Zeng Hengxi, Chen Xi, Liu Fuqian, Yang Bin. Mechanistic investigation into the inhibitory effect of CDK5 on melanin synthesis in melanocytes via a CDC42-MITF signaling pathway [J]. Chinese Journal of Dermatology, 2026, 59(1): 21-27.
[3]	Dai Yeqin, Song Xiuzu. Application of hair follicle transplantation and follicular cell suspension transplantation in the treatment of vitiligo [J]. Chinese Journal of Dermatology, 2025, 58(9): 882-885.
[4]	Song Pu, Liu Yu, Guo Sen, Li Shuli, Liu Ling, Li Chunying. Mast cell-derived chemokine C-C motif ligand 5 affects the migration of CD8+ T cells from vitiligo patients under oxidative stress [J]. Chinese Journal of Dermatology, 2025, 58(9): 839-843.
[5]	Zhou Miaoni, Sheng Anqi, Fu Lifang, Jin Rong, Xu Wen, Wei Xiaodong, Xu Ai′e . Efficacy and safety of an antioxidant gel containing tea polyphenols combined with narrow-band ultraviolet B in the treatment of vitiligo: a single-center randomized controlled trial [J]. Chinese Journal of Dermatology, 2025, 58(9): 834-838.
[6]	Zhang Yude, Wang Hongjuan, Kang Xiaojing. Stem cell therapy for vitiligo: advances in basic and clinical research [J]. Chinese Journal of Dermatology, 2025, 58(9): 878-881.
[7]	Xu Xuqing, Hu Wen, Kang Xiaojing. Cell ferroptosis in the pathogenesis of vitiligo and advances in related therapeutic agents [J]. Chinese Journal of Dermatology, 2025, 58(9): 886-889.
[8]	Zhu Tingting, Li Weiran, Pan Zhaobing, Liu Hao, Tang Xianfa, Zhu Caihong, Huang Hequn, Duan Dawei, Zhang Ruochen, Chen Xiaojian, Wang Yang, Xue Qian, Zhang Jurui, Yang Lijing, Zhang Xuejun, Huang He, Zhang Bo, . Efficacy of baricitinib combined with ruxolitinib cream in the treatment of six patients with progressive nonsegmental vitiligo: a clinical observation [J]. Chinese Journal of Dermatology, 2025, 58(9): 856-859.
[9]	Guliziba·Tuersun, Zhao Yanan, Wang Hongjuan, Kang Xiaojing, Qu Yuanyuan. Efficacy of autologous melanocyte transplantation combined with 308-nm light-emitting diode phototherapy at escalating doses in the treatment of refractory stable vitiligo: a clinical observation [J]. Chinese Journal of Dermatology, 2025, 58(9): 852-856.
[10]	Li Yu, Wang Ziwei, Ye Rongjia, Li Rong, Zhu Yan, Zhang Xiaohua, Huang Dan, Ju Mei. Home-based phototherapy implementation and management needs in patients with vitiligo: a questionnaire survey analysis [J]. Chinese Journal of Dermatology, 2025, 58(7): 608-612.
[11]	Committee on Psoriasis, Chinese Society of Dermatology. Expert proposal on apremilast for the treatment of psoriasis （2025 edition） [J]. Chinese Journal of Dermatology, 2025, 58(5): 416-424.
[12]	Li Ziyu, Lu Yan. Paying attention to severe skin diseases after COVID-19 [J]. Chinese Journal of Dermatology, 2025, 58(4): 378-383.
[13]	Group on Pediatric Dermatology, China Dermatologist Association, Committee on Psoriasis, Chinese Society of Dermatology. Expert consensus on the diagnosis and treatment of pediatric pustular psoriasis in China （2025 version） [J]. Chinese Journal of Dermatology, 2025, 58(4): 297-306.
[14]	He Chunxia, Jin Hongzhong . Principles, current status, challenges and perspectives in the diagnosis and treatment of critical dermatological emergencies [J]. Chinese Journal of Dermatology, 2025, 58(4): 307-314.
[15]	Li Xiuzhen, Xu Xiulian. Effects of interleukin-23 inhibitors on psoriasis comorbidities [J]. Chinese Journal of Dermatology, 2025, 58(3): 268-272.

Memory T cells in chronic autoimmune skin diseases

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［26］

Related Articles 15

Metrics

Comments

Recommended 10